MedTrace Logo

Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam

NCT03219541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2020-04-17

No results posted yet for this study

Summary

The purpose of this study is to develop and then test the feasibility, acceptability, and preliminary effect of a bidirectional text message smoking cessation intervention among Vietnamese smokers in Hanoi, Vietnam. The specific aim are: 1) To develop a smoking cessation text message library among Vietnamese smokers; 2) To evaluate message preferences, and the feasibility and acceptability of the bidirectional text message smoking cessation intervention; and 3) To assess the preliminary effect of a bidirectional mobile phone text message intervention on biochemically validated smoking abstinence.

Conditions

  • Smoking

Interventions

BEHAVIORAL

Interventional Automated mobile phone text

Participants will receive 2 messages per day in the pre-quit phase, 3 messages per day on the quit date and the first week in the post-quit phase, and 2 messages per day in the last 3 weeks of the intervention.

BEHAVIORAL

Control Automated mobile phone text

Participants will receive 2 text questions each week asking the number of smoking days in the past week and the average number of cigarette smoked per day.

Sponsors & Collaborators

Principal Investigators

  • Donna Shelley · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2019-03-13
Completion
2019-03-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03219541 on ClinicalTrials.gov